389 related articles for article (PubMed ID: 17654738)
1. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain.
Haacke EM; Ayaz M; Khan A; Manova ES; Krishnamurthy B; Gollapalli L; Ciulla C; Kim I; Petersen F; Kirsch W
J Magn Reson Imaging; 2007 Aug; 26(2):256-64. PubMed ID: 17654738
[TBL] [Abstract][Full Text] [Related]
2. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study.
Zhang J; Zhang Y; Wang J; Cai P; Luo C; Qian Z; Dai Y; Feng H
Brain Res; 2010 May; 1330():124-30. PubMed ID: 20303339
[TBL] [Abstract][Full Text] [Related]
3. Multispectral quantitative magnetic resonance imaging of brain iron stores: a theoretical perspective.
Jara H; Sakai O; Mankal P; Irving RP; Norbash AM
Top Magn Reson Imaging; 2006 Feb; 17(1):19-30. PubMed ID: 17179894
[TBL] [Abstract][Full Text] [Related]
4. Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study.
Zivadinov R; Heininen-Brown M; Schirda CV; Poloni GU; Bergsland N; Magnano CR; Durfee J; Kennedy C; Carl E; Hagemeier J; Benedict RH; Weinstock-Guttman B; Dwyer MG
Neuroimage; 2012 Jan; 59(1):331-9. PubMed ID: 21820063
[TBL] [Abstract][Full Text] [Related]
5. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
[TBL] [Abstract][Full Text] [Related]
6. Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease.
Ding B; Chen KM; Ling HW; Sun F; Li X; Wan T; Chai WM; Zhang H; Zhan Y; Guan YJ
J Magn Reson Imaging; 2009 Apr; 29(4):793-8. PubMed ID: 19306401
[TBL] [Abstract][Full Text] [Related]
7. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
Bartzokis G; Tishler TA
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
[TBL] [Abstract][Full Text] [Related]
8. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
[TBL] [Abstract][Full Text] [Related]
9. Imaging iron stores in the brain using magnetic resonance imaging.
Haacke EM; Cheng NY; House MJ; Liu Q; Neelavalli J; Ogg RJ; Khan A; Ayaz M; Kirsch W; Obenaus A
Magn Reson Imaging; 2005 Jan; 23(1):1-25. PubMed ID: 15733784
[TBL] [Abstract][Full Text] [Related]
10. Iron stores and cerebral veins in MS studied by susceptibility weighted imaging.
Haacke EM; Garbern J; Miao Y; Habib C; Liu M
Int Angiol; 2010 Apr; 29(2):149-57. PubMed ID: 20351671
[TBL] [Abstract][Full Text] [Related]
11. Enhanced gray and white matter contrast of phase susceptibility-weighted images in ultra-high-field magnetic resonance imaging.
Abduljalil AM; Schmalbrock P; Novak V; Chakeres DW
J Magn Reson Imaging; 2003 Sep; 18(3):284-90. PubMed ID: 12938122
[TBL] [Abstract][Full Text] [Related]
12. Assessing global and regional iron content in deep gray matter as a function of age using susceptibility mapping.
Liu M; Liu S; Ghassaban K; Zheng W; Dicicco D; Miao Y; Habib C; Jazmati T; Haacke EM
J Magn Reson Imaging; 2016 Jul; 44(1):59-71. PubMed ID: 26695834
[TBL] [Abstract][Full Text] [Related]
13. Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study.
Xu X; Wang Q; Zhang M
Neuroimage; 2008 Mar; 40(1):35-42. PubMed ID: 18180169
[TBL] [Abstract][Full Text] [Related]
14. High-field magnetic resonance imaging of brain iron in Alzheimer disease.
Schenck JF; Zimmerman EA; Li Z; Adak S; Saha A; Tandon R; Fish KM; Belden C; Gillen RW; Barba A; Henderson DL; Neil W; O'Keefe T
Top Magn Reson Imaging; 2006 Feb; 17(1):41-50. PubMed ID: 17179896
[TBL] [Abstract][Full Text] [Related]
15. Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).
Du S; Sah SK; Zeng C; Wang J; Liu Y; Xiong H; Li Y
Eur J Radiol; 2015 Jul; 84(7):1325-32. PubMed ID: 25959392
[TBL] [Abstract][Full Text] [Related]
16. Determination of brain iron content in patients with Parkinson's disease using magnetic susceptibility imaging.
Zhang W; Sun SG; Jiang YH; Qiao X; Sun X; Wu Y
Neurosci Bull; 2009 Dec; 25(6):353-60. PubMed ID: 19927171
[TBL] [Abstract][Full Text] [Related]
17. Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.
Martin-Bastida A; Lao-Kaim NP; Loane C; Politis M; Roussakis AA; Valle-Guzman N; Kefalopoulou Z; Paul-Visse G; Widner H; Xing Y; Schwarz ST; Auer DP; Foltynie T; Barker RA; Piccini P
Eur J Neurol; 2017 Feb; 24(2):357-365. PubMed ID: 27982501
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility phase imaging with comparison to R2 mapping of iron-rich deep grey matter.
Walsh AJ; Wilman AH
Neuroimage; 2011 Jul; 57(2):452-61. PubMed ID: 21513807
[TBL] [Abstract][Full Text] [Related]
19. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron.
Hammond KE; Metcalf M; Carvajal L; Okuda DT; Srinivasan R; Vigneron D; Nelson SJ; Pelletier D
Ann Neurol; 2008 Dec; 64(6):707-13. PubMed ID: 19107998
[TBL] [Abstract][Full Text] [Related]
20. Whole-brain susceptibility mapping at high field: a comparison of multiple- and single-orientation methods.
Wharton S; Bowtell R
Neuroimage; 2010 Nov; 53(2):515-25. PubMed ID: 20615474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
